TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
A registered study to follow
This record describes a registered study; no results were posted in this snapshot. Registration, recruitment and completion are different from evidence of effectiveness.
Trial details
- Status at retrieval
- RECRUITING
- Phase
- Phase 1, Phase 2
- Enrollment
- 80 (estimated)
- Registry results
- No results posted
- Last registry update
- 23 Mar 2026
- Conditions
- Atherosclerotic Cardiovascular Diseases; Endothelial Dysfunction
Questions for the community
- Which parts of the study design matter most when interpreting this source?
- What would you need to know before applying the findings to a different population?
The community requires an account and moderator review. Nothing is posted automatically.
Study-design labels are drawn from source metadata or provisional title signals and require verification against the methods. These records are educational references, not treatment recommendations.